Some research has suggested that moderate alcohol consumption can benefit the heart, but new findings suggest that the picture is even more complicated than previously thought.
The SELECT trial catapulted GLP-1 RAs into the forefront of CVD prevention, but cardiologists are making their own decisions about whether and how they might integrate these agents into practice.
The average age of death for Black US patients with sickle cell disease rose from 39 years in 1999-2009 to 43 years in 2010-2020, reflecting improvements in treatment.
Among patients with coronary heart disease, younger age of disease onset is significantly associated with an increased risk for all-cause dementia, Alzheimer's disease, and vascular dementia.
Long-term data showed negligible differences in mortality among hypertensive adults treated with thiazide-type diuretics, calcium channel blockers, or angiotensin-converting enzyme inhibitors.